Clinical Trials Logo

Acute Kidney Injury clinical trials

View clinical trials related to Acute Kidney Injury.

Filter by:

NCT ID: NCT06124105 Not yet recruiting - Sepsis Clinical Trials

Can Urinary Partial Oxygen Pressure be an Indicator of Acute Kidney Injury in Patients With Sepsis?

Start date: March 6, 2024
Phase: N/A
Study type: Interventional

The ability of bladder urinary partial pressure, measured as a reflection of renal medullary oxygen tension, which is an indicator of the development of acute kidney injury (AKI), to predict the development of AKI at an early stage.

NCT ID: NCT06121167 Not yet recruiting - Acute Kidney Injury Clinical Trials

To Examine Whether Urinary Partial Oxygen Pressure Measurements Are Indicative of the Postoperative Occurrence of Acute Kidney Injury (AKI) in Individuals Who Have Undergone Liver Transplantation

Start date: March 6, 2024
Phase:
Study type: Observational

Postoperative acute kidney injury (AKI) is a frequent occurrence among liver transplant recipients and results in considerable mortality and morbidity. The delayed increase in plasma creatinine levels and its susceptibility to external influences, which are utilized in the current diagnostic criteria for AKI, contribute to diagnostic delays. Therefore, numerous biomarkers, including KIM-1, NGAL, TIMP-2, and CYSTATIN C in plasma, along with urine partial oxygen pressure levels and NGAL, are currently under examination to identify acute kidney injury at its early stage. It is well-established that the renal medulla is highly susceptible to hypoxia, which may consequently lead to acute kidney injury. A range of studies have also demonstrated that urine partial oxygen pressure is capable of providing valuable insights into the oxygenation state of the renal medulla. Although urine oxygen pressure measurement is not commonly used, unlike blood gas analysis, urine partial oxygen pressure measurement dates back to 1964. Research among cardiopulmonary bypass patients suggests a correlation between urine partial oxygen pressure data and acute kidney injury. Therefore, we hypothesize that monitoring urine partial oxygen pressure levels may offer insight into the development of acute kidney injury in liver transplant recipients.

NCT ID: NCT06119347 Completed - Clinical trials for AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular Endothelial Growth Factor Monoclonal Antibody vs Immune Checkpoint Inhibitors

Start date: January 1, 2020
Phase:
Study type: Observational

The goal of this a retrospective real-world study is to compare the AKI events in cancer patients receiving anti-vascular endothelial growth factor monoclonal antibody (AntiVEGF) vs immune checkpoint inhibitors (ICIs). The main question it aims to answer is whether the choice between AntiVEGF and ICIs affects the risks of acute kidney injury in cancer patients. Cancer patients receiving AntiVEGF will be compared to those treated with ICIs to see if the AKI incidence is higher in patients receiving ICIs.

NCT ID: NCT06117826 Not yet recruiting - Acute Kidney Injury Clinical Trials

Incidince of Acute Kidney Injury in Children With Community Acquired Pneumonia at Assiut University Children Hospital

Start date: June 30, 2024
Phase:
Study type: Observational

Descriptive prospective observational study of Incidince of acute kidney injury in children with community acquired pneumonia at assiut university children hospital

NCT ID: NCT06114693 Not yet recruiting - Clinical trials for AKI - Acute Kidney Injury

Parameters of the Recovery Time of Acute Kidney Injury in Critically Ill Patients

Start date: January 2024
Phase:
Study type: Observational

the primary objective of this study is to identify and analyze parametrers affecting the time of recovery of AKI in critical ill patient ,Specifically, the study aims to: 1. to identify outcomes of critically ill patients who experienced AKI 2. Examine the relationship between demographic and clinical variables (e.g., age, gender, comorbidities) and outcome of AKI patient 3. follow Baseline characteristics and laboratory findings of the patients at the time of admission to the intensive care unit and affecting it at recovery time 4. Explore the association between psychosocial factors (e.g., depression, anxiety, social support) and outcome of AKI patient at icu

NCT ID: NCT06109714 Not yet recruiting - Acute Kidney Injury Clinical Trials

Early Biomarker Kidney Injury Assessment After Acumen Directed Fluid Management in Cardiac Surgery

BE-KIND
Start date: September 1, 2024
Phase: N/A
Study type: Interventional

This study is to assess the benefits of goal-directed fluid management with ACUMEN in cardiac surgical patients and its impact on cardiac surgery-induced kidney injury.

NCT ID: NCT06108765 Not yet recruiting - Kidney Injury Clinical Trials

Acute Kidney Injury in Poly Trauma Patients

Start date: November 1, 2023
Phase:
Study type: Observational

The aim of this study is to identify the incidence and the factors associated with acute kidney injury in adult poly trauma patients

NCT ID: NCT06108362 Recruiting - Acute Kidney Injury Clinical Trials

Effect of Terlipressin on the Incidence of Early Postoperative Acute Kidney Injury in Liver Transplantation Patients

Start date: August 18, 2023
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to evaluate the effect of intraoperative terlipressin on the incidence of early postoperative acute kidney injury in deceased doner liver transplantation. Patients were randomly divided into experimental group and control group by numerical randomization table. The experimental group was injected with terlipressin perioperative and the control group was injected with placebo

NCT ID: NCT06105229 Recruiting - Acute Kidney Injury Clinical Trials

Clinical Value of Plasma Humanin in Acute Kidney Injury

Start date: August 1, 2022
Phase:
Study type: Observational

The goal of this observational study is to assess the clinical value of humanin in acute kidney injury. The main questions it aims to answer are:whether Humanin can be a novel marker for predicting AKI Researchers will compare humanin concentration in healthy people to see if humanin can be a novel marker for predicting AKI

NCT ID: NCT06101498 Completed - Acute Kidney Injury Clinical Trials

Peroperative Fluid Management in Major Gynecological Cancer Surgeries

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of perioperative fluid management on postoperative kidney damage in gynecological cancer surgeries. The main question[s] it aims to answer are: Does fluid management applied with different hemodynamic monitoring methods affect the risk of postoperative AKI? In our clinic, three different fluid management strategies are applied depending on the anesthetist experience. Acute kidney injury will be evaluated according to the postoperative AKIN classification of conventional fluid therapy and targeted fluid therapy with noninvasive or minimally invasive monitoring.